Repro Med Systems Inc (REPR)

[blue_skies]

budge - was thinking about something and reread your last post. Below is a quote from the post:

" HALO's ability to create infusible formulations out of regimens that require injection is being tested in an increasing number of trials"

What I see here is the beginning of a paradigm shift. There are some drugs, and maybe a large group of drugs, where there might be advantages to being administered via subcutaneous infusion. So as you point out drug makers are re configuring the drugs to be infusible. In addition RMS is partnering with pharma to use subcutaneous infusion in their clinical trials. This is huge